Literature DB >> 11518436

Effectiveness of dynamic cognitive intervention in rehabilitation of clients with schizophrenia.

N Hadas-Lidor1, N Katz, S Tyano, A Weizman.   

Abstract

OBJECTIVE: To examine the efficacy of dynamic cognitive treatment in rehabilitation of schizophrenic clients.
SUBJECTS: Fifty-eight schizophrenic clients that were matched equally into two groups: a study group (n = 29) (treated by Instrumental Enrichment) and a control group (treated with traditional occupational therapy methods).
SETTING: The subjects were treated in a day rehabilitation centre in the community. STUDY
DESIGN: The programme lasted one year, the same schedule was provided for both groups. Subjects were randomly assigned and assessed before and after intervention with the same battery and at a follow-up six months later, work and residence status were evaluated. MAIN OUTCOME MEASURES: Instruments included: (1) memory and thought processes, measured by a battery of structured tests from the Learning Potential Assessment Device (LPAD), Raven Progressive Matrices and General Aptitude Test Battery (GATB); (2) functional outcomes, instrumental activities of daily living (IADL), measured by a questionnaire; work and residence status; (3) self-concept measured with Fitts questionnaire.
RESULTS: Results showed significant differences between the groups on almost all the cognitive tests (MANOVA revealed significant differences between the two groups for both memory and thought process (F(2.52) = 13.75, p < 0.001; and F(1.46) = 7.28, p < 0.001, respectively) as well as in work (chi2 = 14.30, p < 0.001), and residence (chi2 = 3.86, p < 0.05) status. There were no significant differences in IADL questionnaire or the self-concept scale.
CONCLUSIONS: The successful outcome points to the importance of including long-term cognitive intervention in rehabilitation of schizophrenic clients. This work suggests that the classic view of schizophrenia as a progressive irreversible decline that cannot be altered may be wrong.

Entities:  

Mesh:

Year:  2001        PMID: 11518436     DOI: 10.1191/026921501678310153

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  6 in total

1.  Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses.

Authors:  Mario Pfammatter; Ulrich Martin Junghan; Hans Dieter Brenner
Journal:  Schizophr Bull       Date:  2006-08-11       Impact factor: 9.306

2.  The Effects of Occupational Therapy and Psychosocial Interventions on Interpersonal Functioning and Personal and Social Performance Levels of Corresponding Patients.

Authors:  Soner Çakmak; Hüzün Süt; Sibel Öztürk; Lut Tamam; Ufuk Bal
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

3.  Impact of Psychosocial Occupational Therapy Combined with Anodal Transcranial Direct Current Stimulation to the Left Dorsolateral Prefrontal Cortex on the Cognitive Performance of Patients with Schizophrenia: A Randomized Controlled Trial.

Authors:  Elahe Fathi Azar; Samaneh Hosseinzadeh; Masoud Nosrat Abadi; Mohamad Sayad Nasiri; Hojjat Allah Haghgoo
Journal:  Hong Kong J Occup Ther       Date:  2021-12-20       Impact factor: 0.917

Review 4.  A systematic review on improving cognition in schizophrenia: which is the more commonly used type of training, practice or strategy learning?

Authors:  Karine Paquin; Alexa Larouche Wilson; Caroline Cellard; Tania Lecomte; Stéphane Potvin
Journal:  BMC Psychiatry       Date:  2014-05-14       Impact factor: 3.630

Review 5.  Occupational therapy interventions for adults with severe mental illness: a scoping review.

Authors:  María Rocamora-Montenegro; Laura-María Compañ-Gabucio; Manuela Garcia de la Hera
Journal:  BMJ Open       Date:  2021-10-29       Impact factor: 2.692

Review 6.  Efficacy of community treatments for schizophrenia and other psychotic disorders: a literature review.

Authors:  Julio Armijo; Emmanuel Méndez; Ricardo Morales; Sara Schilling; Ariel Castro; Rubén Alvarado; Graciela Rojas
Journal:  Front Psychiatry       Date:  2013-10-09       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.